The issuance comprises three tranches and was about four times covered. Bayer intends to list the bonds on the Regulated Market of the
The three tranches with volumes of
The notes are expected to be rated Baa2, BBB and BBB+ by
'The high level of oversubscription of our new bonds reflects investors' confidence in Bayer's development,' said Bayer CFO
About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2022, the Group employed around 101,000 people and had sales of
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Contact:
Email: tino.andresen@bayer.com
Tel: +49 214 30-66048
(C) 2023 Electronic News Publishing, source